Literature DB >> 1972560

The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots.

P M Green1, A J Montandon, D R Bentley, R Ljung, I M Nilsson, F Giannelli.   

Abstract

The mutations of 76 haemophilia B patients representing the whole population registered with the Malmö haemophilia centre (42) and referrals from the UK, were characterised. RFLP haplotype analysis of the defective genes indicated that 51 single base pair substitutions were definitely of independent origin and 27 of these were CpG----TpG or CpA transitions. This represents a 38-fold excess over other single-base changes. Most of such transitions (82%) occur at 9 CpG sites occupying critical positions (transitions at 3 sites substitute essential arginines, while at 6 sites transition to TpG creates stop codons). Sixteen of the 18 possible transitions at these 9 sites cause clear haemophilia B and should be fully ascertained in our haemophilia B population. This allowed the direct estimate of the rate of CpG transitions. This is 1.05 x 10(-7) substitutions per base per gamete per generation. The marked excess of CpG transitions in haemophilia B appears partly due to the high proportion of CpG sites at critical positions (at least 9 out of 20). We propose that this follows from the fact that male hemizygosity makes X-linked genes particularly susceptible to selective forces that tend to fix CpG sites arising at critical positions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972560      PMCID: PMC330927          DOI: 10.1093/nar/18.11.3227

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

Review 1.  Factor IX.

Authors:  F Giannelli
Journal:  Baillieres Clin Haematol       Date:  1989-10

2.  Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG.

Authors:  D D Koeberl; C D Bottema; J M Buerstedde; S S Sommer
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

3.  Heat-induced depyrimidination of deoxyribonucleic acid in neutral solution.

Authors:  T Lindahl; O Karlström
Journal:  Biochemistry       Date:  1973-12-04       Impact factor: 3.162

4.  Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.

Authors:  S H Chen; A R Thompson; M Zhang; C R Scott
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Blood clotting factor IX BM Nagoya. Substitution of arginine 180 by tryptophan and its activation by alpha-chymotrypsin and rat mast cell chymase.

Authors:  K Suehiro; S Kawabata; T Miyata; H Takeya; J Takamatsu; K Ogata; T Kamiya; H Saito; Y Niho; S Iwanaga
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

6.  Molecular cloning of a cDNA encoding canine factor IX.

Authors:  J P Evans; H H Watzke; J L Ware; D W Stafford; K A High
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

7.  Cytosine methylation and the fate of CpG dinucleotides in vertebrate genomes.

Authors:  D N Cooper; M Krawczak
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

8.  Direct sequencing of the activation peptide and the catalytic domain of the factor IX gene in six species.

Authors:  G Sarkar; D D Koeberl; S S Sommer
Journal:  Genomics       Date:  1990-01       Impact factor: 5.736

9.  Canine hemophilia B resulting from a point mutation with unusual consequences.

Authors:  J P Evans; K M Brinkhous; G D Brayer; H M Reisner; K A High
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

10.  Molecular pathology of haemophilia B.

Authors:  P M Green; D R Bentley; R S Mibashan; I M Nilsson; F Giannelli
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

View more
  37 in total

1.  A new strategy for the genetic counselling of diseases of marked mutational heterogeneity: haemophilia B as a model.

Authors:  F Giannelli; S Saad; A J Montandon; D R Bentley; P M Green
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Haemophilia B: database of point mutations and short additions and deletions--second edition.

Authors:  F Giannelli; P M Green; K A High; S Sommer; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

3.  Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome.

Authors:  B Knebelmann; L Boussin; D Guerrier; L Legeai; A Kahn; N Josso; J Y Picard
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

Review 4.  Progress in the DNA diagnosis of hemophilias.

Authors:  M Goossens; N Ghanem
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

5.  Estimation of DNA sequence context-dependent mutation rates using primate genomic sequences.

Authors:  Wei Zhang; Gerard G Bouffard; Susan S Wallace; Jeffrey P Bond
Journal:  J Mol Evol       Date:  2007-08-04       Impact factor: 2.395

6.  Nonrandom CpG mutations affect the synonymous codon usage of moderately GC-rich single copy actin genes.

Authors:  G Drouin
Journal:  J Mol Evol       Date:  1991-09       Impact factor: 2.395

Review 7.  Biological aspects of cytosine methylation in eukaryotic cells.

Authors:  M Hergersberg
Journal:  Experientia       Date:  1991-12-01

8.  The Italian haemophilia B mutation database: a tool for genetic counselling, carrier detection and prenatal diagnosis.

Authors:  Giuseppe Tagariello; Donata Belvini; Roberta Salviato; Rosanna Di Gaetano; Daniela Zanotto; Paolo Radossi; Renzo Risato; Roberto Sartori; Cristina Tassinari
Journal:  Blood Transfus       Date:  2007-07       Impact factor: 3.443

9.  Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testing.

Authors:  Thomas P Slavin; Bradford Coffee; Ryan Bernhisel; Jennifer Logan; Hannah C Cox; Guido Marcucci; Jeffrey Weitzel; Susan L Neuhausen; Debora Mancini-DiNardo
Journal:  Cancer Genet       Date:  2019-04-13

10.  Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.

Authors:  N Moghrabi; D J Clarke; B Burchell; M Boxer
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.